Search

Search Constraints

You searched for: Author/Creator Lee, Hansol

Search Results

2. Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB–C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial. Issue 7 (July 2019)